{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/143407000"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "1. with other connective tissue diseases; 2. without symptoms; 3. being treated with certain drugs, including procainamide, hydralazine, isoniazid, and chlorpromazine; 4. with conditions other than lupus, such as scleroderma, rheumatoid arthritis, infectious mononucleosis and other chronic infectious diseases such as lepromatous leprosy, subacute bacterial endocarditis, malaria, etc., and liver di" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "lupusinternational.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/352028105"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/143407000"] } } }
